- By January 31, 2023, the Governor shall appoint the initial Natural Medicine Advisory Board
- Beginning June 30, 2024, in coordination with the state licensing authority pursuant to section 44-50-202 (1)(k), annually publish a publicly available report concerning the implementation and administration of this article 170 and article 50 of title 44. The report must use relevant data, as determined by the director and the state licensing authority, and must not disclose the identity of any participant or include any information that could disclose the identity of a participant
- No later than December 31, 2024 - Adopt rules to establish qualifications, education, and training requirements for facilitators and approve required training programs
- No later than December 31, 2024 - Review applications in the form and manner determined by the director for new licenses, registrations, permits, or certificates after payment of the required fee and to grant or deny licenses, registrations, permits, or certificates as provided in this article 170 or a rule promulgated pursuant to this article 170. The division shall prioritize reviewing applications from applicants who have established residency in Colorado.
- Until June 1, 2026, the term “natural medicine” only includes psilocybin and psilocin.
- After June 1, 2026, if recommended by the Natural Medicine Advisory Board, the Department may add one or more of the following to the term “Natural Medicine”: dimethyltryptamine, ibogaine, and mescaline (excluding lophophora williamsii (peyote); may adopt rules prior.
- September 30, 2032 - This article 170 is repealed. Before the repeal, this article 170 is scheduled for review in accordance with section 24-34-104.